HALO logo
halo search icon
Exelixis, Inc.

US$49.90

Price Change Indicator
1.23 (2.53%)
Exelixis, Inc.
EXEL · NAS

Exelixis, Inc.

Start Trading EXEL for Free

US$49.90

Price Arrow1.23 (2.53%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Capital EfficiencyHALO MQVHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Exelixis, Inc. Overview

EXEL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About EXEL

icon
icon

Telephone

1.650.837.7000

icon

Address

1851 Harbor Bay Parkway, Alameda, CA 94502

Description

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

EXEL Price Chart

Key Stats

Market Cap

US$12.23B

PE

15.70

EV/EBITDA

12.2

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 33.76 - 51.63

Trade Value (12mth)

US$30,168,982.00

1 week

-2.91%

1 month

6.06%

YTD

11.68%

1 year

11.32%

All time high

51.63

Key Fundamentals

EPS 3 yr Growth

408.30%

EBITDA Margin

39.70%

Operating Cashflow

$884m

Free Cash Flow Return

37.10%

ROIC

32.80%

Interest Coverage

0.00

Quick Ratio

3.50

Other Data

Shares Outstanding (Fully Diluted)

267m

HALO Sector

Healthcare

Next Company Report Date

09-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

EXEL Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
11 February 26

EXEL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.651.82.88locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.651.762.78locklocklock
Growth
 %locklocklocklock15.2175.260.3locklocklock
PE
 Xlocklocklocklock37.119.315.7locklocklock
EV/EBITDA
 Xlocklocklocklock34.212.412.2locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Exelixis, Inc. (EXEL:NAS)?
Halo FAQ
The current share price of Exelixis, Inc. (EXEL:NAS) is USD$49.90.
What is the 52-week high share price for Exelixis, Inc. (EXEL:NAS)?
Halo FAQ
The 52-week high share price for Exelixis, Inc. (EXEL:NAS) is USD$51.63.
What is the 52-week low share price for Exelixis, Inc. (EXEL:NAS)?
Halo FAQ
The 52-week low share price for Exelixis, Inc. (EXEL:NAS) is USD$33.76.
What is the dividend yield for Exelixis, Inc. (EXEL:NAS)?
Halo FAQ
Exelixis, Inc. (EXEL:NAS) does not pay a dividend.
What was Exelixis, Inc. (EXEL:NAS) last dividend payment?
Halo FAQ
Exelixis, Inc. (EXEL:NAS) does not pay a dividend.
What is the franking level for Exelixis, Inc. (EXEL:NAS)?
Halo FAQ
Exelixis, Inc. (EXEL:NAS) has a franking level of 0.00%.
In which sector is Exelixis, Inc. (EXEL:NAS) classified?
Halo FAQ
Exelixis, Inc. (EXEL:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Exelixis, Inc. (EXEL:NAS)?
Halo FAQ
The current P/E ratio for Exelixis, Inc. (EXEL:NAS) is 15.70.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial